Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use

Addictive Behaviors

Volumn 39, Issue 10, 2014, Pages 1414-1417

  Bohnert, Kipling M ^a,b   Perron, Brian E ^c   Ashrafioun, Lisham ^a,d   Kleinberg, Felicia ^a,b   Jannausch, Mary ^a,b   Ilgen, Mark A ^a,b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

Medical cannabis; Medical marijuana; Posttraumatic stress disorder; Prescription drug use; PTSD

Indexed keywords

ALCOHOL; COCAINE; MEDICAL CANNABIS; OPIATE; SEDATIVE AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS USE; CHRONIC PAIN; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; NAUSEA; NEOPLASM; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; SEIZURE; MASS SCREENING; MIDDLE AGED; OPIOID-RELATED DISORDERS; PREVALENCE; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

ADULT; CHRONIC PAIN; FEMALE; HUMANS; MALE; MASS SCREENING; MEDICAL MARIJUANA; MIDDLE AGED; OPIOID-RELATED DISORDERS; PREVALENCE; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84902344771     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2014.05.022     Document Type: Article

References (18)

1. Abrams T.E., Lund B.C., Bernardy N.C., Friedman M.J. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type. Psychiatric Services 2013, 64:142-148.
2. Berger J. Connecticut allows medical marijuana, but sellers encounter hurdles. The New York Times 2014, (http://www.nytimes.com/2014/05/02/nyregion/medical-marijuana-is-legal-in-connecticut-but-not-yet-sold.html). May 1, 2014 ed.
3. Bohnert K.M., Breslau N. Assessing the performance of the short screening scale for post-traumatic stress disorder in a large nationally-representative survey. International Journal of Methods in Psychiatric Research 2011, 20:e1-e5.
4. Bohnert K.M., Ilgen M.A., Rosen C.S., Desai R.A., Austin K., Blow F.C. The association between substance use disorders and mortality among a cohort of Veterans with posttraumatic stress disorder: variation by age cohort and mortality type. Drug and Alcohol Dependence 2013, 128:98-103.
5. Bonn-Miller M.O., Boden M.T., Bucossi M.M., Babson K.A. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse 2014, 40:23-30.
6. Bonn-Miller M.O., Vujanovic A.A., Drescher K.D. Cannabis use among military veterans after residential treatment for posttraumatic stress disorder. Psychology of Addictive Behaviors 2011, 25:485-491.
7. Breslau N., Peterson E.L., Kessler R.C., Schultz L.R. Short screening scale for DSM-IV posttraumatic stress disorder. The American Journal of Psychiatry 1999, 156:908-911.
8. Brogan B. PTSD added to list of qualifying conditions for medical marijuana treatment. Bangor Daily News 2013, (http://bangordailynews.com/2013/06/30/news/state/ptsd-added-to-list-of-qualifying-conditions-for-medical-marijuana-treatment/). June 30, 2013 ed.
9. Chilcoat H.D., Breslau N. Posttraumatic stress disorder and drug disorders: testing causal pathways. Archives of General Psychiatry 1998, 55:913-917.
10. Cougle J.R., Bonn-Miller M.O., Vujanovic A.A., Zvolensky M.J., Hawkins K.A. Posttraumatic stress disorder and cannabis use in a nationally representative sample. Psychology of Addictive Behaviors 2011, 25:554-558.
11. Ilgen M.A., Bohnert K., Kleinberg F., Jannausch M., Bohnert A.S., Walton M., et al. Characteristics of adults seeking medical marijuana certification. Drug and Alcohol Dependence 2013, 132:654-659.
12. Jacobsen L.K., Southwick S.M., Kosten T.R. Substance use disorders in patients with posttraumatic stress disorder: A review of the literature. The American Journal of Psychiatry 2001, 158:1184-1190.
13. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62:593-602.
14. Oosting J. Michigan medical marijuana law expanding to include post-traumatic stress disorder. Mlive Media Group 2014, (http://www.mlive.com/lansing-news/index.ssf/2014/03/michigan_medical_marijuana_law.html). March 18, 2014 ed.
15. Reinarman C., Nunberg H., Lanthier F., Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 2011, 43:128-135.
16. Vonghia L., Leggio L., Ferrulli A., Bertini M., Gasbarrini G., Addolorato G., et al. Acute alcohol intoxication. European Journal of Internal Medicine 2008, 19:561-567.
17. WHO ASSIST Working Group The Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST): Development reliability and feasibility. Addiction 2002, 97:1183-1194.
18. Zheng Y. Post-traumatic stress sufferers can use medical marijuana, Oregon House says. The Oregonian 2013, (http://www.oregonlive.com/politics/index.ssf/2013/05/post-traumatic_stress_sufferer.html). May 30, 2013 ed.